Showing results (101-110 of 295) with videos related to

Sort By:
Pageof 30
Cell Death & Disease|October 1, 2024
Novel FABP4+C1q+ macrophages enhance antitumor immunity and associated with response to neoadjuvant pembrolizumab and chemotherapy in NSCLC via AMPK/JAK/STAT axisDong Zhang, Min Wang, Gen Liu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 28, 2016
[Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma]Hongliang Ren, Wengui Xu, Jian You, et al.
Oncoimmunology|October 26, 2020
Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging systemZiqing Zeng, Fan Yang, Yunliang Wang, et al.
Cancer Biology & Medicine|August 27, 2021
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapyFan Kou, Lei Wu, Yan Guo, et al.
Future Oncology (London, England)|July 31, 2018
First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III dataXinan Sheng, Feng Bi, Xiubao Ren, et al.
Oncotarget|October 6, 2017
Concurrent somatic mutations in driver genes were significantly correlated with lymph node metastasis and pathological types in solid tumorsYanan Cheng, Shaojing Wang, Lei Han, et al.
Immunotherapy|March 23, 2018
Survival benefit from RectroNectin-activated cytokine-induced killer cells combined with chemotherapy in advanced EGFR wild-type lung adenocarcinomaLingdi Zhao, Wei Li, Zibing Wang, et al.
Annals of Surgical Oncology|February 2, 2013
Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 casesXiangqian Zheng, Songfeng Wei, Ying Han, et al.
BMC Surgery|April 19, 2015
Functional jejunal interposition, a reconstruction procedure, promotes functional outcomes after total gastrectomyXuewei Ding, Fang Yan, Han Liang, et al.
Bulletin Du Cancer|February 4, 2023
Therapeutic effect of haploidentical peripheral blood stem cell treatment on relapsed/refractory ovarian cancerRunmei Li, Dong Zhang, Baozhu Ren, et al.
Pageof 30